Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's diseaseJulien Chapuis, Jean‐Charles Lambert, Faïza Bensemain et al.|Molecular Psychiatry|2009Cited by 203
Genome-wide, high-content siRNA screening identifies the Alzheimer’s genetic risk factor FERMT2 as a major modulator of APP metabolismJean‐Charles Lambert, Anne‐Marie Ayral, Florie Demiautte et al.|Acta Neuropathologica|2016Cited by 78
ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's DiseaseFlorent Letronne, Jean‐Charles Lambert, Anne‐Marie Ayral et al.|EBioMedicine|2016Cited by 52
High‐Content Screening of Synaptic Density Modulators in Primary Neuronal CulturesAudrey Coulon, Julien Chapuis, Anne‐Marie Ayral et al.|Current Protocols|2023Cited by 3
Neuronal downregulation of PLCG2 impairs synaptic function and elicits Alzheimer disease hallmarksJean‐Charles Lambert, Julie Dumont, Anne‐Marie Ayral et al.|Research Square|2024Cited by 1